Overview

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

Determine the localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with active RA and concordance with clinical symptomology.

Phase:

Phase 1

Details

Lead Sponsor:

Navidea Biopharmaceuticals